Table 2.
Time | P Value | ||||||
---|---|---|---|---|---|---|---|
0 | 30 min | 1 h | 4 h | 6 h | Time | Drug | |
IL-8 (pg/ml) | 0.01 | 0.002 | |||||
placebo | 40.2±6.0 | 27.5±4.0a | 28.9±5.1a | 34.1±6.3a | 35.0±5.5 | ||
ARB | 38.2±5.9 | 25.8±3.7a | 30.4±6.2a | 30.5±4.9a | 30.8±4.2a | ||
ACE inhibitor | 31.8±3.6 | 26.4±3.5a | 25.3±4.0a | 26.9±3.0a | 30.1±3.3 | ||
MCP-1 (pg/ml) | <0.001 | 0.51 | |||||
placebo | 415±113 | 277±65a | 264±59a | 332±104a | 387±87 | ||
ARB | 364±108 | 273±61a | 280±56a | 344±79 | 378±108 | ||
ACE inhibitor | 353±74 | 286±48 | 257±53a | 333±58 | 370±83 |
Data are presented as mean ± SEM. MCP-1, monocyte chemoattractant protein-1.
P<0.05 versus baseline.